Yahoo Web Search

Search results

1. www.nasdaq.com › articles › analyst-expectationsAnalyst Expectations For ConocoPhillips's Future - Nasdaq

   www.nasdaq.com › articles › analyst-expectations

   • Cached

   6 hours ago · 0. 0. In the assessment of 12-month price targets, analysts unveil insights for ConocoPhillips, presenting an average target of $142.78, a high estimate of $153.00, and a low estimate of $120.00 ...

2. jamanetwork.com › journals › jamanetworkopenEstimated Sustainable Cost-Based Prices for Diabetes Medicines

   jamanetwork.com › journals › jamanetworkopen

   • Cached

   Mar 27, 2024 · This economic evaluation study estimated the cost of production for insulins, SGLT2Is, and GLP1As, and, based on this, a sustainable cost-based price (CBP), and compared CBPs with the current lowest reported prices in 12 countries, collected in January 2023 from public databases.

3. www.nature.com › articles › s43856/021/00004-4Insulin at 100: still central in protein-based therapy for ...

   www.nature.com › articles › s43856/021/00004-4

   Jun 30, 2021 · Here, we describe how insulin as a model protein will drive future advances in peptide- and protein-based therapies for chronic diseases.

   • Author: Peter Kurtzhals, Bernt Johan von Scholten, Frederik Flindt Kreiner, Stephen Charles Langford Gough

   • Publish Year: 2021

4. www.nature.com › articles › s41591/021/01418-2100 years of insulin: celebrating the past, present and ...

   www.nature.com › articles › s41591/021/01418-2

   Jul 15, 2021 · Decades of scientific accomplishment have transformed diabetes treatment; this Review describes key milestones in our understanding of the insulin molecule and looks to the future of insulin...

   • Author: Emily K. Sims, Alice L. J. Carr, Richard A. Oram, Linda A. DiMeglio, Carmella Evans-Molina

   • Publish Year: 2021

5. link.springer.com › article › 10Current advances and future prospects in production of ...

   link.springer.com › article › 10

   • Cached

   Apr 17, 2022 · Transient plant expression system produces insulin in large quantities in short time and can be scaled up quickly to provide gram quantities of product in less than 4 weeks. Among all production platforms, transient plant expression method significantly reduced the time and cost required for insulin production over conventional methods.

6. www.tandfonline.com › doi › pdfRecent advances and near future of insulin production and therapy

   www.tandfonline.com › doi › pdf

   Recent advances in production of insulin via MSCs have shown to be promising. Results from testing the efficacy of MSC use in animals have provided advantages, but some disadvantages still exist.

7. People also ask

   Are conventional insulin production platforms successful?

   • The conventional insulin production platforms (Escherichia coli, Saccharomyces cerevisiae and mammalian cell lines) with limited scalability and high upstream process costs have not been successful in meeting the rapidly increasing insulin demands.

   Current advances and future prospects in production of ... - Springer

   link.springer.com/article/10.1007/s10529-022-03247-w

   See all results for this question

   What are the future developments in insulin delivery?

   • Future developments in this area will also be centred around insulin and be assisted by automatisation and digitalisation. Insulin pumps coupled with glucose-monitoring systems are being developed to allow for automated insulin delivery in response to the ambient blood glucose level 10.

   Insulin at 100: still central in protein-based therapy for chronic

   www.nature.com/articles/s43856-021-00004-4

   See all results for this question

   Do insulin phospholipid complexes with deformable nanovesicles improve permeability of high-molecular-weight?

   • Insulin–phospholipid complexes (IPCs) with deformable nanovesicles (DNVs) were developed as a model to address issues of the poor permeability of high-molecular-weight therapeutic drugs for buccal delivery. It was observed that insulin deposition in the mucosa was much higher in the IPC-DNVs as compared to the conventional nanovesicles (IPC-NVs).

   A Comprehensive Review of the Evolution of Insulin Development and Its

   www.ncbi.nlm.nih.gov/pmc/articles/PMC9320488/

   See all results for this question

8. www.ncbi.nlm.nih.gov › pmc › articlesA Comprehensive Review of the Evolution of Insulin ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jul 4, 2022 · The amount of insulin was increase from 5 IU to 10 and 20 IU to be loaded into the microneedle, which resulted in a rapid decrease in blood glucose level, followed by a slow increase to the initial level. The relative bioavailability of insulin was further analyzed.